Infinity Pharmaceuticals, Inc. (INFI) Tops Q1 EPS by 6c

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) reported Q1 EPS of ($0.78), $0.06 better than the analyst estimate of ($0.84).

For earnings history and earnings-related data on Infinity Pharmaceuticals, Inc. (INFI) click here.

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance
• HSBC Upgrades Pegatron Corp. (4938:TT) to Hold